808-P: Parent Characteristics Associated with Diabetes Device Use in Young Children Newly Diagnosed with Type 1 Diabetes (T1D)

Abstract

Introduction: Diabetes devices may improve glycemic control in young children (YC) with T1D. However, little is known about which families are most likely to start using diabetes devices soon after diagnosis. This study examined relationships among demographics, parent mood and anxiety, and continuous glucose monitor (CGM) and insulin pump use in YC in approximately the first 6 months post-diagnosis. Methods: Participants were 157 parent-child dyads, newly diagnosed with T1D (child age M=4.5 years, 90% mothers, 61% White, 75% married), enrolled in a RCT. Parents completed the Center for Epidemiological Studies-Depression Scale (CES-D) and PROMIS-A (parental anxiety) to assess mood and anxiety. Diabetes device use was assessed by parent-report. About six months after diagnosis, parents again completed the CES-D and provided updates on diabetes device use. χ2 tests were used to compare device use based on parent mood/anxiety and demographics. Results: At baseline, 20% of YC used CGM (M days post-diagnosis =27.4±15) and 2.5% used insulin pumps. At first check-in (M days post-diagnosis= 163.4±51.3), 57% used CGM and 14% used pumps. CGM use at 6 months was not related to anxiety at baseline or depression at either timepoint, but was significantly related to higher income (p<.01), married parents (p<.01), and non-Hispanic White race/ethnicity (p<.01). YC were more likely to use pumps at 6 months if parents were non-Hispanic White (p<.05) and had private insurance (p<.05). Discussion: Parent mood and anxiety were not related to early device use, but non-Hispanic White families with married parents and higher SES were more likely to adopt devices soon after diagnosis. Future studies should explore the directionality of these relationships to draw more definitive conclusions about the disparities associated with early device use in YC. Further research exploring characteristics of families who maintain or stop using devices over time may inform clinical care. Disclosure M. Sinisterra: None. J. Jacangelo: None. C.H. Wang: None. C. Tully: None. M. Monaghan: Research Support; Self; American Diabetes Association. M.E. Hilliard: None. R. Streisand: None. Funding National Institutes of Health (R01DK102561)